Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB01035_nanopub.RAh9jTdtX2DoReoxaYneWA-m6kttWvjgOaMxqGSwQTXkY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB01035 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB01035 label "DDI between Trimethoprim and Procainamide - Trimethoprim may reduce the clearance of Procainamide. Alternative treatments should be considered. If Trimethoprim is initiated or the dose is increased, monitor for increased toxicity of Procainamide (e.g. QTc intervals, EKG, serum drug concentrations). If Trimethoprim is discontinued or the dose decreased, monitor for reduced effects of Procainamide. [drugbank_resource:DB00440_DB01035]" assertion.
- drugbank_resource:DB00440_DB01035 identifier "drugbank_resource:DB00440_DB01035" assertion.
- drugbank_resource:DB00440_DB01035 title "DDI between Trimethoprim and Procainamide - Trimethoprim may reduce the clearance of Procainamide. Alternative treatments should be considered. If Trimethoprim is initiated or the dose is increased, monitor for increased toxicity of Procainamide (e.g. QTc intervals, EKG, serum drug concentrations). If Trimethoprim is discontinued or the dose decreased, monitor for reduced effects of Procainamide." assertion.
- drugbank:DB01035 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB01035 assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB01035 assertion.